Naglah Ahmed M, Almehizia Abdulrahman A, Ghazwani Mohammed, Al-Wasidi Asma S, Naglah Abdelrahman A, Aboulthana Wael M, Hassan Ashraf S
Drug Exploration & Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Department of Pharmaceutics, College of Pharmacy, King Khalid University, P.O. Box 1882, Abha 61441, Saudi Arabia.
Pharmaceutics. 2025 Feb 23;17(3):293. doi: 10.3390/pharmaceutics17030293.
: Recently, the prevalence of diseases such as diabetes, arthritis, and inflammatory diseases, along with their complications, has become a significant health problem. This is in addition to the various biomedical applications of pyrazole, isatin, and indole derivatives. Accordingly, cooperation will continue between chemistry scientists, pharmaceutical scientists, and human doctors to produce hybrid compounds from pyrazole with isatin or indole possessing biological activities as anti-diabetic, anti-arthritic, and anti-inflammatory agents. : The two series of pyrazole-isatin conjugates - and pyrazole-indole conjugates - were prepared from our previous works via the direct reaction of 5-amino-pyrazoles - with -alkyl isatin ,, and 1-indole-3-carbaldehyde (), respectively, using the previously reported procedure. The potential biological activities of - and - as anti-diabetic, anti-arthritic, and anti-inflammatory agents were assessed through estimated inhibition percentage (%) and the median inhibitory concentrations (IC) using methods described in the literature. Further, the computational assessments of - and - such as toxic doses (the median lethal dose, LD), toxicity classes, drug-likeness model scores (DLMS), molecular lipophilicity potential (MLP) maps, polar surface area (PSA) maps, and topological polar surface area (TPSA) values were predicted using available free websites. : The in vitro enzymatic assessment results showed that pyrazole-indole conjugate possesses powerful activities against (i) α-amylase (% = 65.74 ± 0.23, IC = 4.21 ± 0.03 µg/mL) and α-glucosidase (% = 55.49 ± 0.23, IC = 2.76 ± 0.01 µg/mL); (ii) the protein denaturation enzyme (% = 49.30 ± 0.17) and against the proteinase enzyme (% = 46.55 ± 0.17) with an IC value of 6.77 ± 0.01 µg/mL; (iii) the COX-1, COX-2, and 5-LOX enzymes with an IC of 5.44 ± 0.03, 5.37 ± 0.04, and 7.52 ± 0.04, respectively, which is almost close to the IC of the indomethacin and zileuton drugs. Also, the computational assessment results showed (i) the conjugate possesses lipophilic surface properties thus can cross cell membranes, and is effective for treatment; (ii) all the conjugates possess a TPSA value of more than 140 Å thus possess good intestinal absorption. : The two series of pyrazole-isatin conjugates - and pyrazole-indole conjugates - were synthesized from our previous works. The results of these in vitro enzymatic and computational assessments concluded that the pyrazole-indole conjugate possesses powerful activities against various studied enzymes and possesses good computational results. In the future, our research team will present in vitro, in vivo biological, and computational assessments to hopefully obtain effectual agents such as anti-diabetic, anti-arthritic, and anti-inflammatory.
最近,糖尿病、关节炎和炎症性疾病等疾病及其并发症的患病率已成为一个重大的健康问题。这还不包括吡唑、异吲哚酮和吲哚衍生物的各种生物医学应用。因此,化学科学家、制药科学家和医生之间将继续合作,以制备具有抗糖尿病、抗关节炎和抗炎剂等生物活性的吡唑与异吲哚酮或吲哚的杂化化合物。:通过我们之前的工作,分别使用先前报道的方法,通过5-氨基吡唑与烷基异吲哚酮和1-吲哚-3-甲醛的直接反应,制备了两系列吡唑-异吲哚酮共轭物和吡唑-吲哚共轭物。通过文献中描述的方法,通过估计抑制百分比(%)和半数抑制浓度(IC)评估了作为抗糖尿病、抗关节炎和抗炎剂的潜在生物活性。此外,使用可用的免费网站预测了的毒性剂量(半数致死剂量,LD)、毒性类别、药物相似性模型评分(DLMS)、分子亲脂性潜力(MLP)图、极性表面积(PSA)图和拓扑极性表面积(TPSA)值等计算评估。:体外酶促评估结果表明,吡唑-吲哚共轭物对(i)α-淀粉酶(% = 65.74 ± 0.23,IC = 4.21 ± 0.03 µg/mL)和α-葡萄糖苷酶(% = 55.49 ± 0.23,IC = 2.76 ± 0.01 µg/mL)具有强大的活性;(ii)对蛋白质变性酶(% = 49.30 ± 0.17)和蛋白酶(% = 46.55 ± 0.17),IC值为6.77 ± 0.01 µg/mL;(iii)对COX-1、COX-2和5-LOX酶的IC分别为5.44 ± 0.03、5.37 ± 0.04和7.52 ± 0.04,这几乎与消炎痛和齐留通药物的IC接近。此外,计算评估结果表明(i)共轭物具有亲脂性表面性质,因此可以穿过细胞膜,并且对治疗有效;(ii)所有共轭物的TPSA值均大于140 Å,因此具有良好的肠道吸收。:两系列吡唑-异吲哚酮共轭物和吡唑-吲哚共轭物是根据我们之前的工作合成的。这些体外酶促和计算评估的结果得出结论,吡唑-吲哚共轭物对各种研究的酶具有强大的活性,并且具有良好的计算结果。未来,我们的研究团队将进行体外、体内生物学和计算评估,以期获得抗糖尿病药、抗关节炎药和抗炎药等有效药物。